This Is Not About Money: Deepinder Goyal Defends Temple Amid Credibility Row
In brief
Deepinder Goyal, founder of Temple, a brain-monitoring wearable, defended the product after doctors and social media users questioned its scientific validity. Goyal said Temple has spent $30 Mn on development, including $20 Mn of his own money, and that a 14-day return policy would test the product in the market. He said the device is a fitness and wellness tracker, not a medical device, and that it has not been clinically validated. Critics, including doctors, challenged the claim that a sensor near the temple measures brain blood flow. Pre-orders opened November 1 at ₹85,000.
From the publisher
Addressing social media debates over the scientific validity of Temple’s eponymous brain-monitoring wearable, founder Deepinder Goyal issued a statement directed…Excerpt from Inc42
Why it matters for student founders
Credibility is a founder's most valuable asset, and a bold scientific claim needs evidence before it reaches customers. Be precise about what your product does and does not do, especially in health. Funding and personal investment do not replace independent validation.
The headline and excerpt belong to Inc42. "In brief" and "Why it matters" are written by STARTIONS from the published story.
